BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 36248831)

  • 21. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
    Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
    Front Immunol; 2021; 12():744887. PubMed ID: 34712232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
    Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
    JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination.
    Oktelik FB; Yilmaz V; Gelmez MY; Akdeniz N; Pamukcu C; Sutlu T; Kose M; Tuzun E; Deniz G
    Can J Microbiol; 2022 Aug; 68(8):543-550. PubMed ID: 35852365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.
    Wang H; Yan D; Li Y; Gong Y; Mai Y; Li B; Zhu X; Wan X; Xie L; Jiang H; Zhang M; Sun M; Yao Y; Zhu Y
    Infect Dis Poverty; 2022 Feb; 11(1):15. PubMed ID: 35109926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.
    Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H
    Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples.
    Szymczak A; Jędruchniewicz N; Torelli A; Kaczmarzyk-Radka A; Coluccio R; Kłak M; Konieczny A; Ferenc S; Witkiewicz W; Montomoli E; Miernikiewicz P; Bąchor R; Dąbrowska K
    J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34816794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients.
    Liao B; Chen Z; Zheng P; Li L; Zhuo J; Li F; Li S; Chen D; Wen C; Cai W; Wu S; Tang Y; Duan L; Wei P; Chen F; Yuan J; Yang J; Feng J; Zhao J; Zhao J; Sun B; Zhu A; Li Y; Tang X
    Front Immunol; 2021; 12():724763. PubMed ID: 34489978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
    Planchais C; Fernández I; Bruel T; de Melo GD; Prot M; Beretta M; Guardado-Calvo P; Dufloo J; Molinos-Albert LM; Backovic M; Chiaravalli J; Giraud E; Vesin B; Conquet L; Grzelak L; Planas D; Staropoli I; Guivel-Benhassine F; Hieu T; Boullé M; Cervantes-Gonzalez M; Ungeheuer MN; Charneau P; van der Werf S; Agou F; ; ; Dimitrov JD; Simon-Lorière E; Bourhy H; Montagutelli X; Rey FA; Schwartz O; Mouquet H
    J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35704748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection.
    Sim KY; Ko GH; Bae SE; Choi KY; Lee JS; Kim BC; Lee KH; Song MR; Park SG
    Front Immunol; 2021; 12():813240. PubMed ID: 35087532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.
    Brynjolfsson SF; Sigurgrimsdottir H; Einarsdottir ED; Bjornsdottir GA; Armannsdottir B; Baldvinsdottir GE; Bjarnason A; Gudlaugsson O; Gudmundsson S; Sigurdardottir ST; Love A; Kristinsson KG; Ludviksson BR
    Front Immunol; 2021; 12():695230. PubMed ID: 34177962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
    Miyamoto S; Nishiyama T; Ueno A; Park H; Kanno T; Nakamura N; Ozono S; Aihara K; Takahashi K; Tsuchihashi Y; Ishikane M; Arashiro T; Saito S; Ainai A; Hirata Y; Iida S; Katano H; Tobiume M; Tokunaga K; Fujimoto T; Suzuki M; Nagashima M; Nakagawa H; Narita M; Kato Y; Igari H; Fujita K; Kato T; Hiyama K; Shindou K; Adachi T; Fukushima K; Nakamura-Uchiyama F; Hase R; Yoshimura Y; Yamato M; Nozaki Y; Ohmagari N; Suzuki M; Saito T; Iwami S; Suzuki T
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2314808120. PubMed ID: 38134196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.
    Harrington WE; Trakhimets O; Andrade DV; Dambrauskas N; Raappana A; Jiang Y; Houck J; Selman W; Yang A; Vigdorovich V; Yeung W; Haglund M; Wallner J; Oldroyd A; Hardy S; Stewart SWA; Gervassi A; Van Voorhis W; Frenkel L; Sather DN
    Cell Rep Med; 2021 Apr; 2(4):100253. PubMed ID: 33842901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile.
    Rubio R; Aguilar R; Bustamante M; Muñoz E; Vázquez-Santiago M; Santano R; Vidal M; Melero NR; Parras D; Serra P; Santamaria P; Carolis C; Izquierdo L; Gómez-Roig MD; Dobaño C; Moncunill G; Mazarico E
    Front Immunol; 2022; 13():999136. PubMed ID: 36238312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Ota K; Sakai H; Sasaki D; Mitsumoto-Kaseida F; Sakamoto K; Kosai K; Hasegawa H; Takazono T; Izumikawa K; Mukae H; Tun MMN; Morita K; Yanagihara K
    Virus Res; 2024 Jan; 339():199294. PubMed ID: 38056502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.